- Home
- SRPT vs BSAC Comparison
SRPT vs BSAC Comparison
Compare SRPT & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- BSAC
- Stock Information
- Founded
- SRPT 1980
- BSAC 1977
- Country
- SRPT United States
- BSAC Chile
- Employees
- SRPT N/A
- BSAC N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- BSAC Commercial Banks
- Sector
- SRPT Health Care
- BSAC Finance
- Exchange
- SRPT Nasdaq
- BSAC Nasdaq
- Market Cap
- SRPT N/A
- BSAC 11.5B
- IPO Year
- SRPT 1997
- BSAC 1994
- Fundamental
- Price
- SRPT $36.52
- BSAC $24.52
- Analyst Decision
- SRPT Buy
- BSAC Hold
- Analyst Count
- SRPT 23
- BSAC 3
- Target Price
- SRPT $131.09
- BSAC $21.33
- AVG Volume (30 Days)
- SRPT 3.8M
- BSAC 529.6K
- Earning Date
- SRPT 05-06-2025
- BSAC 04-30-2025
- Dividend Yield
- SRPT N/A
- BSAC 4.08%
- EPS Growth
- SRPT N/A
- BSAC 111.01
- EPS
- SRPT N/A
- BSAC 0.01
- Revenue
- SRPT $2,233,371,000.00
- BSAC $2,379,764,303.00
- Revenue This Year
- SRPT $64.51
- BSAC $39.14
- Revenue Next Year
- SRPT $22.40
- BSAC $5.12
- P/E Ratio
- SRPT N/A
- BSAC $10.71
- Revenue Growth
- SRPT 59.15
- BSAC 49.00
- 52 Week Low
- SRPT $35.46
- BSAC $18.14
- 52 Week High
- SRPT $173.25
- BSAC $24.90
- Technical
- Relative Strength Index (RSI)
- SRPT 22.82
- BSAC 59.45
- Support Level
- SRPT $59.62
- BSAC $23.12
- Resistance Level
- SRPT $64.80
- BSAC $24.77
- Average True Range (ATR)
- SRPT 3.75
- BSAC 0.55
- MACD
- SRPT -1.21
- BSAC -0.00
- Stochastic Oscillator
- SRPT 3.61
- BSAC 78.65
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About BSAC Banco Santander - Chile ADS
Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.